Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. POCI Peers
See (POCI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| POCI | $4.95 | +0.00% | 37M | -5.31 | -$0.91 | N/A |
| ISRG | $540.60 | +0.00% | 195.1B | 79.72 | $6.83 | N/A |
| BDX | $177.27 | +0.00% | 50.5B | 34.14 | $5.16 | +2.31% |
| BDXA | $59.24 | -2.24% | 48.7B | 21.44 | $2.76 | +2.31% |
| ALC | $89.30 | +0.00% | 43.4B | 39.01 | $2.25 | +0.38% |
| RMD | $255.88 | +0.00% | 37.7B | 28.84 | $8.91 | +0.83% |
| WST | $221.22 | +0.00% | 16B | 34.89 | $6.37 | +0.37% |
| BAX | $31.13 | +0.00% | 15.9B | -59.63 | -$0.52 | +2.58% |
| COO | $73.02 | +0.00% | 14.6B | 35.41 | $2.07 | N/A |
| HOLX | $65.30 | +0.00% | 14.4B | 27.22 | $2.38 | N/A |
Stock Comparison
POCI vs ISRG Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ISRG has a market cap of 195.1B. Regarding current trading prices, POCI is priced at $4.95, while ISRG trades at $540.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ISRG's P/E ratio is 79.72. In terms of profitability, POCI's ROE is -0.54%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, POCI is less volatile compared to ISRG. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BDX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, BDX has a market cap of 50.5B. Regarding current trading prices, POCI is priced at $4.95, while BDX trades at $177.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas BDX's P/E ratio is 34.14. In terms of profitability, POCI's ROE is -0.54%, compared to BDX's ROE of +0.06%. Regarding short-term risk, POCI is more volatile compared to BDX. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs BDXA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, BDXA has a market cap of 48.7B. Regarding current trading prices, POCI is priced at $4.95, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas BDXA's P/E ratio is 21.44. In terms of profitability, POCI's ROE is -0.54%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, POCI is less volatile compared to BDXA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ALC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ALC has a market cap of 43.4B. Regarding current trading prices, POCI is priced at $4.95, while ALC trades at $89.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ALC's P/E ratio is 39.01. In terms of profitability, POCI's ROE is -0.54%, compared to ALC's ROE of +0.07%. Regarding short-term risk, POCI is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs RMD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, RMD has a market cap of 37.7B. Regarding current trading prices, POCI is priced at $4.95, while RMD trades at $255.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas RMD's P/E ratio is 28.84. In terms of profitability, POCI's ROE is -0.54%, compared to RMD's ROE of +0.25%. Regarding short-term risk, POCI is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs WST Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, WST has a market cap of 16B. Regarding current trading prices, POCI is priced at $4.95, while WST trades at $221.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas WST's P/E ratio is 34.89. In terms of profitability, POCI's ROE is -0.54%, compared to WST's ROE of +0.17%. Regarding short-term risk, POCI is less volatile compared to WST. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BAX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, BAX has a market cap of 15.9B. Regarding current trading prices, POCI is priced at $4.95, while BAX trades at $31.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas BAX's P/E ratio is -59.63. In terms of profitability, POCI's ROE is -0.54%, compared to BAX's ROE of -0.08%. Regarding short-term risk, POCI is less volatile compared to BAX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs COO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, COO has a market cap of 14.6B. Regarding current trading prices, POCI is priced at $4.95, while COO trades at $73.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas COO's P/E ratio is 35.41. In terms of profitability, POCI's ROE is -0.54%, compared to COO's ROE of +0.05%. Regarding short-term risk, POCI is more volatile compared to COO. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs HOLX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, HOLX has a market cap of 14.4B. Regarding current trading prices, POCI is priced at $4.95, while HOLX trades at $65.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas HOLX's P/E ratio is 27.22. In terms of profitability, POCI's ROE is -0.54%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, POCI is more volatile compared to HOLX. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs BDXB Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, POCI is priced at $4.95, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas BDXB's P/E ratio is 7.60. In terms of profitability, POCI's ROE is -0.54%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, POCI is less volatile compared to BDXB. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ATR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ATR has a market cap of 10.6B. Regarding current trading prices, POCI is priced at $4.95, while ATR trades at $160.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ATR's P/E ratio is 29.44. In terms of profitability, POCI's ROE is -0.54%, compared to ATR's ROE of +0.15%. Regarding short-term risk, POCI is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs MASI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, MASI has a market cap of 9.1B. Regarding current trading prices, POCI is priced at $4.95, while MASI trades at $171.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas MASI's P/E ratio is -30.63. In terms of profitability, POCI's ROE is -0.54%, compared to MASI's ROE of -0.41%. Regarding short-term risk, POCI is less volatile compared to MASI. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs RGEN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, RGEN has a market cap of 7.2B. Regarding current trading prices, POCI is priced at $4.95, while RGEN trades at $126.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas RGEN's P/E ratio is -303.50. In terms of profitability, POCI's ROE is -0.54%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, POCI and RGEN have similar daily volatility (2.02).
POCI vs STVN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, STVN has a market cap of 6.7B. Regarding current trading prices, POCI is priced at $4.95, while STVN trades at $24.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas STVN's P/E ratio is 46.40. In terms of profitability, POCI's ROE is -0.54%, compared to STVN's ROE of +0.09%. Regarding short-term risk, POCI is less volatile compared to STVN. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MMSI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, POCI is priced at $4.95, while MMSI trades at $93.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas MMSI's P/E ratio is 45.87. In terms of profitability, POCI's ROE is -0.54%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, POCI is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs TFX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, TFX has a market cap of 5.3B. Regarding current trading prices, POCI is priced at $4.95, while TFX trades at $121.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas TFX's P/E ratio is 37.12. In terms of profitability, POCI's ROE is -0.54%, compared to TFX's ROE of +0.03%. Regarding short-term risk, POCI is more volatile compared to TFX. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs BLCO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, BLCO has a market cap of 4.9B. Regarding current trading prices, POCI is priced at $4.95, while BLCO trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas BLCO's P/E ratio is -13.60. In terms of profitability, POCI's ROE is -0.54%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, POCI is less volatile compared to BLCO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs HAE Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, HAE has a market cap of 3.7B. Regarding current trading prices, POCI is priced at $4.95, while HAE trades at $76.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas HAE's P/E ratio is 23.22. In terms of profitability, POCI's ROE is -0.54%, compared to HAE's ROE of +0.18%. Regarding short-term risk, POCI is more volatile compared to HAE. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs ICUI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ICUI has a market cap of 3.3B. Regarding current trading prices, POCI is priced at $4.95, while ICUI trades at $136.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ICUI's P/E ratio is -35.36. In terms of profitability, POCI's ROE is -0.54%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, POCI is less volatile compared to ICUI. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs XRAY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, XRAY has a market cap of 3.3B. Regarding current trading prices, POCI is priced at $4.95, while XRAY trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas XRAY's P/E ratio is -3.73. In terms of profitability, POCI's ROE is -0.54%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, POCI is less volatile compared to XRAY. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs WRBY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, WRBY has a market cap of 2.7B. Regarding current trading prices, POCI is priced at $4.95, while WRBY trades at $21.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas WRBY's P/E ratio is -185.33. In terms of profitability, POCI's ROE is -0.54%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, POCI is less volatile compared to WRBY. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs QDEL Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, QDEL has a market cap of 2B. Regarding current trading prices, POCI is priced at $4.95, while QDEL trades at $30.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas QDEL's P/E ratio is -5.77. In terms of profitability, POCI's ROE is -0.54%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, POCI is less volatile compared to QDEL. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NVCR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, POCI is priced at $4.95, while NVCR trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NVCR's P/E ratio is -11.76. In terms of profitability, POCI's ROE is -0.54%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, POCI is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs LMAT Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, POCI is priced at $4.95, while LMAT trades at $83.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas LMAT's P/E ratio is 42.84. In terms of profitability, POCI's ROE is -0.54%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, POCI is less volatile compared to LMAT. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NNNN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NNNN has a market cap of 1.6B. Regarding current trading prices, POCI is priced at $4.95, while NNNN trades at $36.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NNNN's P/E ratio is 736.60. In terms of profitability, POCI's ROE is -0.54%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, POCI is less volatile compared to NNNN. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ATRC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ATRC has a market cap of 1.6B. Regarding current trading prices, POCI is priced at $4.95, while ATRC trades at $31.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ATRC's P/E ratio is -39.21. In terms of profitability, POCI's ROE is -0.54%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, POCI is less volatile compared to ATRC. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs AZTA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, POCI is priced at $4.95, while AZTA trades at $32.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas AZTA's P/E ratio is -10.16. In terms of profitability, POCI's ROE is -0.54%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, POCI is less volatile compared to AZTA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BLFS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, BLFS has a market cap of 1.1B. Regarding current trading prices, POCI is priced at $4.95, while BLFS trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas BLFS's P/E ratio is -120.21. In terms of profitability, POCI's ROE is -0.54%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, POCI is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs PLSE Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, PLSE has a market cap of 1B. Regarding current trading prices, POCI is priced at $4.95, while PLSE trades at $15.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas PLSE's P/E ratio is -15.51. In terms of profitability, POCI's ROE is -0.54%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, POCI is less volatile compared to PLSE. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs STAA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, STAA has a market cap of 884.5M. Regarding current trading prices, POCI is priced at $4.95, while STAA trades at $17.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas STAA's P/E ratio is -12.40. In terms of profitability, POCI's ROE is -0.54%, compared to STAA's ROE of -0.18%. Regarding short-term risk, POCI is less volatile compared to STAA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ATRI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, POCI is priced at $4.95, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ATRI's P/E ratio is 64.50. In terms of profitability, POCI's ROE is -0.54%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, POCI is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs KMTS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, KMTS has a market cap of 804.6M. Regarding current trading prices, POCI is priced at $4.95, while KMTS trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas KMTS's P/E ratio is -8.16. In terms of profitability, POCI's ROE is -0.54%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, POCI is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ANGO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ANGO has a market cap of 389M. Regarding current trading prices, POCI is priced at $4.95, while ANGO trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ANGO's P/E ratio is -9.39. In terms of profitability, POCI's ROE is -0.54%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, POCI is less volatile compared to ANGO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NYXH Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NYXH has a market cap of 293.1M. Regarding current trading prices, POCI is priced at $4.95, while NYXH trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NYXH's P/E ratio is -3.36. In terms of profitability, POCI's ROE is -0.54%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, POCI is less volatile compared to NYXH. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs SMTI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, SMTI has a market cap of 263.5M. Regarding current trading prices, POCI is priced at $4.95, while SMTI trades at $29.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas SMTI's P/E ratio is -22.13. In terms of profitability, POCI's ROE is -0.54%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, POCI is less volatile compared to SMTI. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs OSUR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, OSUR has a market cap of 230.4M. Regarding current trading prices, POCI is priced at $4.95, while OSUR trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas OSUR's P/E ratio is -7.33. In terms of profitability, POCI's ROE is -0.54%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, POCI is less volatile compared to OSUR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs UTMD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, UTMD has a market cap of 189.8M. Regarding current trading prices, POCI is priced at $4.95, while UTMD trades at $57.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas UTMD's P/E ratio is 15.42. In terms of profitability, POCI's ROE is -0.54%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, POCI is more volatile compared to UTMD. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs STXS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, STXS has a market cap of 189.2M. Regarding current trading prices, POCI is priced at $4.95, while STXS trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas STXS's P/E ratio is -7.10. In terms of profitability, POCI's ROE is -0.54%, compared to STXS's ROE of -2.17%. Regarding short-term risk, POCI is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs KRMD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, KRMD has a market cap of 167M. Regarding current trading prices, POCI is priced at $4.95, while KRMD trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas KRMD's P/E ratio is -30.17. In terms of profitability, POCI's ROE is -0.54%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, POCI is less volatile compared to KRMD. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs PDEX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, PDEX has a market cap of 155.9M. Regarding current trading prices, POCI is priced at $4.95, while PDEX trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas PDEX's P/E ratio is 17.33. In terms of profitability, POCI's ROE is -0.54%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, POCI is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs INFU Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, INFU has a market cap of 129.2M. Regarding current trading prices, POCI is priced at $4.95, while INFU trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas INFU's P/E ratio is 41.07. In terms of profitability, POCI's ROE is -0.54%, compared to INFU's ROE of +0.08%. Regarding short-term risk, POCI is less volatile compared to INFU. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ZTEK Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ZTEK has a market cap of 115.8M. Regarding current trading prices, POCI is priced at $4.95, while ZTEK trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ZTEK's P/E ratio is -15.86. In terms of profitability, POCI's ROE is -0.54%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, POCI is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ZJYL Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ZJYL has a market cap of 102.7M. Regarding current trading prices, POCI is priced at $4.95, while ZJYL trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ZJYL's P/E ratio is 32.79. In terms of profitability, POCI's ROE is -0.54%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, POCI is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MBOT Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, MBOT has a market cap of 96M. Regarding current trading prices, POCI is priced at $4.95, while MBOT trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas MBOT's P/E ratio is -4.12. In terms of profitability, POCI's ROE is -0.54%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, POCI is less volatile compared to MBOT. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs AKYA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, AKYA has a market cap of 67.9M. Regarding current trading prices, POCI is priced at $4.95, while AKYA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas AKYA's P/E ratio is -1.42. In terms of profitability, POCI's ROE is -0.54%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, POCI is less volatile compared to AKYA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MLSS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, MLSS has a market cap of 52.6M. Regarding current trading prices, POCI is priced at $4.95, while MLSS trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas MLSS's P/E ratio is -11.17. In terms of profitability, POCI's ROE is -0.54%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, POCI is less volatile compared to MLSS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs OMIC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, POCI is priced at $4.95, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas OMIC's P/E ratio is -0.58. In terms of profitability, POCI's ROE is -0.54%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, POCI is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs IGAP Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, POCI is priced at $4.95, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas IGAP's P/E ratio is -10.52. In terms of profitability, POCI's ROE is -0.54%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, POCI is less volatile compared to IGAP. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs DXR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, DXR has a market cap of 49M. Regarding current trading prices, POCI is priced at $4.95, while DXR trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas DXR's P/E ratio is -109.67. In terms of profitability, POCI's ROE is -0.54%, compared to DXR's ROE of +0.02%. Regarding short-term risk, POCI is less volatile compared to DXR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NEPH Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NEPH has a market cap of 42.7M. Regarding current trading prices, POCI is priced at $4.95, while NEPH trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NEPH's P/E ratio is 50.38. In terms of profitability, POCI's ROE is -0.54%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, POCI is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs SDC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, POCI is priced at $4.95, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas SDC's P/E ratio is -0.03. In terms of profitability, POCI's ROE is -0.54%, compared to SDC's ROE of -1.96%. Regarding short-term risk, POCI is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs FEMY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, FEMY has a market cap of 27.1M. Regarding current trading prices, POCI is priced at $4.95, while FEMY trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas FEMY's P/E ratio is -1.02. In terms of profitability, POCI's ROE is -0.54%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, POCI is less volatile compared to FEMY. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs IVC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, POCI is priced at $4.95, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas IVC's P/E ratio is -0.79. In terms of profitability, POCI's ROE is -0.54%, compared to IVC's ROE of -0.46%. Regarding short-term risk, POCI is less volatile compared to IVC. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NXGL Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NXGL has a market cap of 20.3M. Regarding current trading prices, POCI is priced at $4.95, while NXGL trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NXGL's P/E ratio is -5.89. In terms of profitability, POCI's ROE is -0.54%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, POCI is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs HBIO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, HBIO has a market cap of 19.9M. Regarding current trading prices, POCI is priced at $4.95, while HBIO trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas HBIO's P/E ratio is -0.34. In terms of profitability, POCI's ROE is -0.54%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, POCI is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs RVP Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, RVP has a market cap of 19.5M. Regarding current trading prices, POCI is priced at $4.95, while RVP trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas RVP's P/E ratio is -0.86. In terms of profitability, POCI's ROE is -0.54%, compared to RVP's ROE of -0.27%. Regarding short-term risk, POCI is less volatile compared to RVP. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs WOK Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, WOK has a market cap of 17.7M. Regarding current trading prices, POCI is priced at $4.95, while WOK trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas WOK's P/E ratio is -2.63. In terms of profitability, POCI's ROE is -0.54%, compared to WOK's ROE of -0.30%. Regarding short-term risk, POCI is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NXGLW Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NXGLW has a market cap of 17.2M. Regarding current trading prices, POCI is priced at $4.95, while NXGLW trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NXGLW's P/E ratio is -0.19. In terms of profitability, POCI's ROE is -0.54%, compared to NXGLW's ROE of -0.63%. Regarding short-term risk, POCI is more volatile compared to NXGLW. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs MHUA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, MHUA has a market cap of 13.9M. Regarding current trading prices, POCI is priced at $4.95, while MHUA trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas MHUA's P/E ratio is 1.09. In terms of profitability, POCI's ROE is -0.54%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, POCI is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs EKSO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, EKSO has a market cap of 7.9M. Regarding current trading prices, POCI is priced at $4.95, while EKSO trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas EKSO's P/E ratio is -0.46. In terms of profitability, POCI's ROE is -0.54%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, POCI is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs POAI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, POAI has a market cap of 7.7M. Regarding current trading prices, POCI is priced at $4.95, while POAI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas POAI's P/E ratio is -0.60. In terms of profitability, POCI's ROE is -0.54%, compared to POAI's ROE of -5.91%. Regarding short-term risk, POCI is less volatile compared to POAI. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs LUCY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, LUCY has a market cap of 6.6M. Regarding current trading prices, POCI is priced at $4.95, while LUCY trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas LUCY's P/E ratio is 0.05. In terms of profitability, POCI's ROE is -0.54%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, POCI is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs STSS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, STSS has a market cap of 6M. Regarding current trading prices, POCI is priced at $4.95, while STSS trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas STSS's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to STSS's ROE of -0.99%. Regarding short-term risk, POCI is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NSTG Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, POCI is priced at $4.95, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas NSTG's P/E ratio is -0.03. In terms of profitability, POCI's ROE is -0.54%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, POCI is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs LUCYW Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, LUCYW has a market cap of 4.6M. Regarding current trading prices, POCI is priced at $4.95, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas LUCYW's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, POCI is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs GCTK Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, GCTK has a market cap of 3.7M. Regarding current trading prices, POCI is priced at $4.95, while GCTK trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas GCTK's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, POCI is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs GMVD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, POCI is priced at $4.95, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas GMVD's P/E ratio is -0.01. In terms of profitability, POCI's ROE is -0.54%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, POCI is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs GMVDW Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, POCI is priced at $4.95, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas GMVDW's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, POCI is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs AVGR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, POCI is priced at $4.95, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas AVGR's P/E ratio is -0.05. In terms of profitability, POCI's ROE is -0.54%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, POCI is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs HRC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, HRC has a market cap of 0. Regarding current trading prices, POCI is priced at $4.95, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas HRC's P/E ratio is 41.92. In terms of profitability, POCI's ROE is -0.54%, compared to HRC's ROE of +0.14%. Regarding short-term risk, POCI is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs ATRS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, POCI is priced at $4.95, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas ATRS's P/E ratio is 14.95. In terms of profitability, POCI's ROE is -0.54%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, POCI is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs LMNX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, LMNX has a market cap of 0. Regarding current trading prices, POCI is priced at $4.95, while LMNX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas LMNX's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to LMNX's ROE of +0.03%. Regarding short-term risk, POCI is more volatile compared to LMNX. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs IIN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, IIN has a market cap of 0. Regarding current trading prices, POCI is priced at $4.95, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas IIN's P/E ratio is 226.45. In terms of profitability, POCI's ROE is -0.54%, compared to IIN's ROE of -0.00%. Regarding short-term risk, POCI is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs APR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 37M. In comparison, APR has a market cap of 0. Regarding current trading prices, POCI is priced at $4.95, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -5.31, whereas APR's P/E ratio is 22.59. In terms of profitability, POCI's ROE is -0.54%, compared to APR's ROE of +9.81%. Regarding short-term risk, POCI is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.